SCHEMBL18355482

SCHEMBL18355482

CNCc1ccc(/C=C\c2ccc(C(=O)O)o2)o1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.46
POLB P06746 3/20 0.46
MEN1 O00255 2/20 0.46
APOBEC3A P31941 1/20 0.46
CTDSP1 Q9GZU7 1/20 0.46
APOBEC3G Q9HC16 1/20 0.46
TDP1 Q9NUW8 2/20 0.45
HDAC4 P56524 5/20 0.43
HDAC1 Q13547 5/20 0.43
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
MAPK1 P28482 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
HDAC3 O15379 2/20 0.38
HDAC7 Q8WUI4 2/20 0.38
HDAC2 Q92769 2/20 0.38
HDAC10 Q969S8 2/20 0.38
HDAC11 Q96DB2 2/20 0.38
HDAC8 Q9BY41 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18355598 0.80 TDP1 (0.49) KMT2APOLBMEN1TDP1HDAC4
SCHEMBL14624779 0.73 ALDH1A1 (0.57) POLBAPOBEC3AAPOBEC3GTDP1NPC1
SCHEMBL21654213 0.73 MEN1 (0.46) KMT2AMEN1TDP1HDAC4HDAC1
SCHEMBL15366286 0.73 MEN1 (0.46) KMT2AMEN1TDP1HDAC4HDAC1
SCHEMBL4153690 0.70 HTT (0.49) KMT2APOLBMEN1APOBEC3ACTDSP1
SCHEMBL17491863 0.70 KMT2A (0.54) KMT2APOLBMEN1TDP1HDAC4
SCHEMBL17491864 0.70 KMT2A (0.54) KMT2APOLBMEN1TDP1HDAC4
SCHEMBL21653998 0.69 HDAC4 (0.41) KMT2AMEN1TDP1HDAC4HDAC1
SCHEMBL183229 0.69 HDAC4 (0.41) KMT2AMEN1TDP1HDAC4HDAC1
SCHEMBL21654138 0.69 HDAC4 (0.41) KMT2APOLBMEN1TDP1HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9994677-B2 Methods and compounds for producing nylon 12 EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) 2018-06-12 US disclosed
US-20170002142-A1 METHODS AND COMPOUNDS FOR PRODUCING NYLON 12 EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) 2017-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170002142-A1 METHODS AND COMPOUNDS FOR PRODUCING NYLON 12 CYP4F12, PFAS, RPL12 KMT2A 2292/4885POLB 4312/4885MEN1 3373/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.